ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Clin Pharmacol Biopharm; 2022, Vol 11(4): 264
  • DOI: 10.4172/2167-065X.1000264

Insulin: The medication of Type 1 Diabetes

Mohamed Sayed*
College of Pharmacy, King Saud University, Saudi Arabia
*Corresponding Author : Mohamed Sayed, College of Pharmacy, King Saud University, Saudi Arabia, Email: sayedmoh996@gmail.com

Received Date: Apr 04, 2022 / Accepted Date: Apr 19, 2022 / Published Date: Apr 26, 2022

Citation: Sayed M (2022) Insulin: The medication of Type 1 Diabetes. Clin Pharmacol Biopharm, 11: 264. Doi: 10.4172/2167-065X.1000264

Copyright: © 2022 Sayed M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top